Structural glycobiology: A game of snakes and ladders

Glycobiology

Volumn 18, Issue 6, 2008, Pages 426-440

  DeMarco, Mari L ^a   Woods, Robert J ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Binding free energy; Docking; Molecular dynamics; Nomenclature; Oxidative footprinting

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; MONOSACCHARIDE; SUGAR;

BINDING KINETICS; CARBOHYDRATE ANALYSIS; CHEMICAL MODEL; CHEMICAL STRUCTURE; COMPLEX FORMATION; COMPUTER PROGRAM; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; GLYCOBIOLOGY; HUMAN; MASS SPECTROMETRY; MATHEMATICAL COMPUTING; MICROARRAY ANALYSIS; MOLECULAR DOCKING; NOMENCLATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CARBOHYDRATE INTERACTION; REVIEW; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; THERMODYNAMICS; THREE DIMENSIONAL IMAGING;

SERPENTES;

EID: 44449128912     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn026     Document Type: Review

References (151)

1. Archontis G, Watson KA, Xie Q, Andreou G, Chrysina ED, Zographos SE, Oikonomakos NG, Karplus M. 2005. Glycogen phosphorylase inhibitors: A free energy perturbation analysis of glucopyranose spirohydantoin analogues. Proteins. 61:984-998.
2. Babu YS, Chand P. Bantia S. Kotian P. Dehghani A. El-Kattan Y. Lin TH, Hutchison TL, Elliot AJ, et al. 2000. BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem. 43:3482-3486.
3. Baker D. 2000. A surprising simplicity to protein folding. Nature. 405:39-42.
4. Banin E, Neuberger Y, Altshuler Y, Halevi A, Inbar O, Nir D, Dukler A. 2002. A novel linear code nomenclature for complex carbohydrates. Trends Glycoscience Glycotechnol. 14:127-137.
5. Bern M, Cai Y, Goldberg D. 2007. Lookup peaks: A hybrid of de novo sequencing and database search for protein identification by tandem mass spectrometry. Anal Chem. 79:1393-1400.
6. Bhunia A, Jayalakshimi V, Bernie AJ, Schuster O, Kelm S, Krishna NR, Peters T. 2004. Saturation transfer difference NMR and computational modeling of a sialoadhesin-sialyl lactose complex. Carbohydr Res. 339:259-267.
7. Bichard CJF, Mitchell EP, Wormald MR. Watson KA, Johnson LN, Zographos SE, Koutra DD, Oikonomakos NG, Fleet, GWJ. 1995. Potent inhibition of glycogen phosphorylase by a spirohydantoin of glucopyranose: First pyranose analogues of hydantocidin. Tetrahednon Lett. 36:2145.
8. Biet T and Peters T. 2001. Molecular recognition of UDP-Gal by beta-1,4- galactosyltransferase T1. Angew Chem, Int Ed. 40:4189-4192.
9. Bitomsky W and Wade RC. 1999. Docking of glycosaminoglycans to heparin-binding proteins: Validation for aFGF, bFGF, and antithrombin and application to IL-8. J Am Chem Soc. 121:3004-3013.
10. Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, Alvarez R, Bryan MC, Fazio F, Calarese D, et al. 2004. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA. 101:17033-17038.
11. Bohne-Lang A, Lang E, Forster T, von der Lieth C-W. 2001. LINUCS: Linear notation for unique description of ca carbohydrate, sequences. Carbohydr Res. 336:1.
12. Brooks BR, Bruccoleti RE, Olafson BD, States DJ, Swaminathan S. Karplus M. 19883. CHARMM: A program. for macromolecular energy, minimization, and dynamics calculations. J Comput Chem. 4:187-217.
13. Brown GD and Gordon S. 2001. Immune recognition: A new receptor for b-glucans. Nature. 413:36.
14. Bryce RA, Hillier IH, Naismith JH. 2001. Carbohydrate-protein recognition: Molecular dynamics simulations and free energy analysis of oligosaccharide binding to concanavalin A. Biophys J. 81:1373-1388.
15. Bundle DR, Eichler E, Gidney MA, Meldal M, Ragauskas A, Sigurskjold BW, Sinnott B, Watson DC, Yaguchi M, et al. 1994. Molecular recognition of a Salmonella trisaccharide epitope by monoclonal antibody Se155-4. Biochemistry. 33:5172 5182.
16. Buskas T, Ingale S, Boons GJ. 2005. Towards a fully synthetic carbohydrate-based anticancer vaccine: Synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated Tn antigen. Angew Chem Int Ed. 44:5985-5988.
17. Campbell BJ, Yu LG, Rhodes JM. 2001. Altered glycosylation in inflammatory bowel disease: A possible role in cancer developtuent. Glycoconj J. 18:851-858.
18. Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, et al. 2005. The AMBER biomolecular simulation programs. J Comput Chem. 26:1668-1688.
19. Casset F, Hamelryck T, Loris R, Brisson J-R, Tellier C, Dao-Thi M-H, Wyns L. Poortmans F. Pérez S. et al. 1995. NMR, molecular modeling, and crystallographic studies of lentil lectin-sucrose interaction. J Biol Chem. 270:25619-25628.
20. Chand P, Kotian PL, Dehghani A, El-Kattan Y, Lin TH, Hutchison TL, Babu YS, Bantia S, Elliott AJ, et al. 2001. Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity. J Med Chem. 44:4379-4392.
21. Cobb BA and Kasper DL. 2005. Coming of age: Carbohydrates and immunity. Eur J Immunol. 35:352-356.
22. Coppo R and Amore A. 2004. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int. 65:1544-1547.
23. Corzana F, Bettler E, Herve du Penhoat C, Tyrtysh TV, Bovin NV, Imberty A. 2002. Solution structure of two xenoantigens: AGal-LacNAc and aGal-Lewis X. Glycobiology. 12:241-250.
24. Corzana F, Motawia MS, Du Penhoat CH, Perez S, Tschampel SM, Woods RJ, Engelsen SB. 2004. A hydration study of (1→4) and (1→6) linked alpha-glucans by comparative 10 ns molecular dynamics simulations and 500-MHz NMR. J Comput Chem. 25:573-586.
25. Dreitlein WB, Maratos J, Brocavich J. 2001. Zanamivir and oseltamivir: Two new options for the treatment and prevention of influenza. Clin Ther. 23:327-355.
26. Dwek RA. 1996. Glycobiology: Toward understanding the function of sugars. Chem Rev. 96:683-720.
27. Eklund R, Lycknert K, Soderman P, Widmalm G. 2005. A conformational dynamics study of α-L-Rhap-(1-2)[α-L-Rhap (1-3)]-α-L-Rhap-OMe in solution by NMR experiments and molecular simulations. J Phys Chem B. 109:19936-19945.
28. Ewing TJA and Kuntz ID. 1997. Critical evaluation of search algorithms for automated molecular docking and database screening. J Comput Chem 18:1175-1189.
29. Fichtinger-Schepman AMJ, Kamerling JP, Versluis C, Vliegenthart JFG. 1981. Structural studies of the methylated, acidic polysaccharide associated with coccoliths of Emiliania huxleyi (lohmann) kamptner. Carbohydr Res. 93-105.
30. Fichtinger-Schepman AMJ, Kamerling JP, Vliegenthart JFG. 1979. Composition of a methylated, acidic polysaccharide associated with coccoliths of Emiliania huxleyi (lohmann). Carbohydr Res. 69:181-189.
31. Finley JB, Atigadda VR, Duarte F, Zhao JJ, Brouillette WJ, Air GM, Luo M. 1999. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site. J Mol Biol. 293:1107.
32. Ford MG, Weimar T, Kohli T, Woods RJ. 2003. Molecular dynamics simulations of galectin-1-oligosaccharide complexes reveal the molecular basis for ligand diversity. Proteins. 53:229-240.
33. Freeze HH. 2001. Update and perspectives on congenital disorders of glycosylation. Glycobiology. 11:129r-143r.
34. Fukuda M. 1996. Possible roles of tumor-associated carbohydrate antigens. Cancer Res. 56:2237-2244.
35. Fukui S, Feizi T, Galustian C, Lawson AM, Chai W. 2002. Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nat Biotech. 20:1011.
36. Galas DJ and Schmitz A. 1978. DNAase footprinting - simple method for detection of protein-DNA binding specificity. Nucleic Acids Res. 5:3157-3170.
37. Gessler K, Uson I, Takaha T, Krauss N, Smith SM, Okada S, Sheldrick GM, Saenger W. 1999. V-Amylose at atomic resolution: X-ray structure of a cycloamylose with 26 glucose residues (Cyclomaltohexaicosaose). Proc Natl Acad Sci USA. 96:4246-4251.
38. Gonzalez-Outeirino J, Kadirvelraj R, Woods RJ. 2005. Structural elucidation of type III group B Streptococcus capsular polysaccharide using molecular dynamics simulations: The role of sialic acid. Carbohydr Res. 340:1007-1018.
39. Gonzalez-Outeirino J, Kirschner KN, Thobhani S, Woods RJ. 2006. Reconciling solvent effects on rotamer populations in carbohydrates - a joint MD and NMR analysis. Can J Chem. 84:569-579.
40. Goodford PJ. 1985. A computational-procedure for determining energetically favorable binding-sites on biologically important macromolecules. J Med Chem. 28:849-857.
41. Goodsell DS, Morris GM, Olson AJ. 1996. Automated docking of flexible ligands: Applications of AutoDock. J Mol Recognit. 9:1-5.
42. Goodsell DS and Olson AJ. 1990. Automated docking of substrates to proteins by simulated annealing. Proteins. 8:195-202.
43. Grabowski GA and Hopkin RJ. 2003. Enzyme therapy for lysosomal storage disease: Principles, practice, and prospects. Annu Rev Genom Hum Gen 4:403-436.
44. Gregoriou M, Noble MEM, Watson KA, Garman EF, Krulle TM, De-La-Fuente C, Fleet GWJ, Oikonomakos NG, Johnson LN. 1998. The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 Å resolution and 100 K: The role of the water structure and its contribution to binding. Protein Sci. 7:915-927.
45. Hakomori SI. 1989. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res. 52:257-331.
46. Haltiwanger RS and Lowe JB. 2004. Role of glycosylation in development. Annu Rev Biochem. 73:491-537.
47. Hambly DM and Gross ML. 2005 Laser flash photolysis of hydrogen peroxide to oxidize protein solvent-accessible residues on the microsecond timescale. J Am Soc Mass Spectrom. 16:2057-2063.
48. Haselhorst T, Blanchard H, Frank M, Kraschnefski MJ, Kiefel MJ, Szyczew AJ, Dyason JC, Fleming F, Holloway G, et al. 2007. STD NMR spectroscopy molecular modeling investigation of the binding of N acetylneuraminic acid derivatives to rhesus rotavirus VP8* core. Glycobiology. 17:68-81.
49. Haselhorst T, Wilson X, Thomson RJ, McAtamney S, Menting JG, Coppel RL, von Itzstein M. 2004. Saturation transfer difference (STD) H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase. Proteins. 56:346-353.
50. Herget S, Ranzinger R, von der Lieth. CW. 2007. A sequence format and namespace for complex oligo- and polysaccharides (http://www.eurocarbdb.org/recommendations/encoding).
51. Imberty A and Perez S. 2000. Structure, conformation, and dynamics of bioactive oligosaccharides: Theoretical approaches and experimental validations. Chem Rev. 100:4567-4588.
52. Jayalakshmi V and Rama Krishna N. 2004. CORCEMA refinement of the bound ligand conformation within the protein binding pocket in reversibly forming weak complexes using STD-NMR intensities. J Magn Reson. 168:36.
53. Jedrzejas MJ, Singh S, Brouillette WJ, Air GM, Luo M. 1995. A strategy for theoretical binding constant, K-I, calculations for neuraminidase aromatic inhibitors designed on the basis of the active-site structure of influenza-virus neuraminidase. Proteins. 23:264-277.
54. Jennings H. 1992. Further approaches for optimizing polysaccharide-protein conjugate vaccines for prevention of invasive bacterial disease. J Infect Dis. 165(Suppl 1):S156-159.
55. Jennings HJ, Lugowski C, Kasper DL. 1981. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide. Biochemistry. 20:4511-4518.
56. Johnson MA and Pinto BM. 2004. Saturation-transfer difference NMR studies for the epitope mapping of a carbohydrate-mimetic peptide recognized by an anti-carbohydrate antibody. Bioorg Med Chem. 12:295.
57. Kadirvelraj R, Gonzalez-Outeirino J. Foley BL, Beckham ML, Jennings HJ, Foote S, Ford MG, Woods RJ. 2006. Understanding the bacterial polysaccharide antigenicity of Streptococcus agalactiae versus Streptococcus pneumoniae. Proc Natl Acad Sci USA. 103:8149-8154.
58. Karaveg K and Moremen KW. 2005. Energetics of substrate binding and catalysis by class 1 (Glycosylhydrolase family 47) α-mannosidases involved in N-glycan processing and endoplasmic reticulum quality control. J B iol Chem. 280:29837-29848.
59. Karaveg K, Siriwardena A, Tempel W, Liu Z-J, Glushka J, Wang B-C, Moremen KW. 2005. Mechanism of class 1 (Glycosylhydrolase family 47) α-mannosidases involved in N-glycan processing and endoplasmic reticulum quality control. J Biol Chem. 280:16197-16207.
60. Karlsson K-A. 1986. Animal glycolipids as attachment sites for microbes. Chem Phys Lipids. 42:153.
61. Karlsson K-A. 1989. Animal glycosphingolipids as membrane attachment sites for bacteria. Annu Rev Biochem. 58:309-150.
62. Kendall RA, Apra E. Bernholdt DE, Bylaska EJ, Dupuis M. Fann GI, Harrison RJ, Ju J, Nichols JA, et al. 2000. High performance computational chemistry: An overview of NWChem a distributed parallel application. Comput Phys Commun. 128:260.
63. King D, Lumpkin M, Bergmann C, Orlando R. 2002. Studying protein-carbohydrate interactions by amide hydrogen/deuterium exchange mass spectrometry. Rapid Commun Mass Spectrom. 16:1569-1574.
64. Kirschner KN and Woods RJ. 2001. Solvent interactions determine carbohydrate conformation. Proc Natl Acad Sci USA. 98: 10541-10545.
65. Kirschner KN, Yongye A, Tschampel SM, González-Outeiriño J, Daniels C, Woods RJ. 2008. GLYCAM06: A generalizable biomolecular force field. Carbohydrates. J Comput Chem. 29:622-655.
66. Kuschert GSV, Hooggewerf AJ, Proudfoot AEI, Chung Cw, Cooke RM, Hubbard RE, Wells TNC, Sanderson PN. 1998. identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 37:11193-11201.
67. Landersjo C, Jansson JLM, Maliniak A, Widmalm G. 2005. Conformational analysis of a tetrasaccharide based on NMR spectroscopy and molecular dynamics simulations. J Phys Chem B. 109:17320-17326.
68. Liao DI, Kapadia G, Ahmed H, Vasta GR, Herzberg O. 1994. Structure of S-lectin, a developmentally regulated vertebrate b-galactoside-binding protein. Proc Natl Acad Sci USA. 91:1428-1432.
69. Liu C, Eichelberger MC, Compans RW, Air GM. 1995. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol. 69:1099-1106.
70. Lo-Man R, Vichier-Guerre S, Perraut R, Deriaud E, Huteau V, BenMohamed L, Diop OM, Livingston PO, Bay S, et al. 2004. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res. 64:4987-4994.
71. Lopez-Lucendo MF, Solis D, Andre S, Hirabayashi J, Kasai K-i, Kaltner H, Gabius H-J, Romero A. 2004. Growth-regulatory human galectin-1: Crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J Mol Biol. 343:957.
72. Lütteke T, Frank M, von der Lieth C-W. 2005. Carbohydrate structure suite (CSS): Analysis of carbohydrate 3D structures derived from the PDB. Nucl Acids Res. 33:D242-D246.
73. Maaheimo H, Kosma P, Brade L, Brade H, Peters T. 2000. Mapping the binding of synthetic disaccharides representing epitopes of chlamydial lipopolysaccharide to antibodies with NMR. Biochemistry. 39:12778-12788.
74. MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, et al. 1998. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102:3586-3616.
75. Macnaughtan MA, Kamar M, Alvarez-Manilla G, Venot A, Glushka J, Pierce JM and Prestegard JH. 2007. NMR structural characterization of substrates bound to N-acetylglucosaminyltransferase V. J Mol Biol. 366:1266.
76. Malhotra R, Wormald MR, Rudd PM, Fishcher PB, Dwek RA, Sim RB. 1995. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med. 1:237-243.
77. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A. 2000. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct. 29:291-325.
78. Masukawa KM, Kollman PA, Kuntz ID. 2003. Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations. J Med Chem. 46:5628-5637.
79. Mayer M and Meyer B. 1999. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem, Int Ed 38:1784-1788.
80. Mayer M and Meyer B. 2001. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc. 123:6108-6117.
81. McNaught AD. 1997. Nomenclature of carbohydrates (recommendations 1996). Carbohydr Res. 297:1.
82. Merritt EA, Sarfaty S, Feil IK, Hol WG. 1997. Structural foundation for the design of receptor antagonists targeting Escherichia coli heat-labile enterotoxin. Structure. 5:1485-1499.
83. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, Teller E. 1953. Equation of state calculations by fast computing machines. J Chem Phys. 21:1087-1092.
84. Metropolis N and Ulam S. 1949. The Monte Carlo method. J Am Stat Assoc. 44:335-341.
85. Meyer B and Peters T. 2003. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew Chem, Int Ed. 42:864-890.
86. Minke WE, Diller DJ, Hol WGJ and Verlinde CLMJ. 1999. The role of waters in docking strategies with incremental flexibility for carbohydrate derivatives: Heat-labile enterotoxin, a multivalent test case. J Med Chem. 42:1778-1788.
87. Minke WE, Roach C, Hol WGJ, Verlinde CLMJ. 1999. Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists. Biochemistry. 38:5684-5692.
88. Moseley HNB, Curto EV, Krishna NR. 1995. Complete relaxation and conformational exchange matrix (CORCEMA) analysis of NOESY spectra of interacting systems - 2-dimensional transferred NOESY. J Magn Reson B 108:243-261.
89. Motoki I, Yosinari S, Watanabe K, Nishikawa K. 1991. Structural analyses on yeast tRNA(Tyr) and its complex with tyrosyl-tRNA synthetase by the use of hydroxyl radical 'footprinting'. Nucleic Acids Symp Ser. 173-174.
90. Moura IC, Arcos-Fajardo M, Sadaka C, Leroy V, Benhamou M, Novak J, Vrtovsnik F, Haddad E, Chintalacharuvu KR, et al. 2004. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol. 15:622-634.
91. Mulakala C, Nerinckx W and Reilly PJ. 2006. Docking studies on glycoside hydrolase family 47 endoplasmic reticulum a-(1→2)-mannosidase I to elucidate the pathway to the substrate transition state. Carbohydr Res. 341:2233.
92. Naidoo KJ, Denysyk D, Brady JW. 1997. Molecular dynamics simulations of the N-linked oligosaccharide of the lectin from Erythrina corallodendron. Protein Eng. 10:1249-1261.
93. Neufeld EF. 1991 Lysosomal storage diseases. Annu Rev Biochem. 60:257-280.
94. Nishiyama Y, Langan P, Chanzy H. 2002. Crystal structure and hydrogen-bonding system in cellulose 1 beta from synchrotron x-ray and neutron fiber diffraction. J Am Chem Soc. 124:9074-9082.
95. a, from synchrotron x-ray and neutron fiber diffraction. J Am Chem Soc. 125:14300-14306.
96. Oikonomakos NG, Skamnaki VT, Osz E, Szilagyi L, Somsak L, Docsa T, Toth B, Gergely P. 2002. Kinetic and crystallographic studies of glucopyranosylidene spirothiohydantoin binding to glycogen phosphorylase b. Bioorg Med Chem. 10:261.
97. Österberg F, Morris GM, Sanner ME, Olson AJ, Goodsell DS. 2002. Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins. 46:34-40.
98. Palese P and Compans RW. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N trifluoroacetylneuraminic acid (FANA): Mechanism of action. J Gen Virol. 33:159-163.
99. Palese P, Tobita K, Ueda M, Compans RW. 1974. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology. 61:397.
100. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, et al. 1985. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum Ig-G. Nature. 316:452-457.
101. Pathiaseril A and Woods RJ. 2000. Relative energies of binding for antibody-carbohydrate-antigen complexes computed from free-energy simulations. J Am Chem Soc. 122:331-338.
102. Paulson JC, Blixt O, Collins BE. 2006. Sweet spots in functional glycomics. Nat Chem Biol. 2:238.
103. Pereira CS, Kony D, Baron R, Muller M, van Gunsteren WF, Hunenberger PH. 2006. Conformational and dynamical properties of disaccharides in water: A molecular dynamics study. Biophys J. 90:4337-4344.
104. Perkins DN, Pappin DJC, Creasy DM, Cottrell JS. 1999. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 20:3551-3567.
105. Petrescu AJ, Petrescu SM, Dwek RA, Wormald MR. 1999. A statistical analysis of N- and O-glycan linkage conformations from crystallographic data. Glycobiology. 9:343-352.
106. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, et al. 2005. Scalable molecular dynamics with NAMD. J Comput Chem. 26:1781-1802.
107. Picard C, Gruza J, Derouet C, Renard C, Mazeau K, Koca J, Imberty A, du Penhoat CH. 2000. A conformational study of the xyloglucan oligomer, XXXG, by NMR spectroscopy and molecular modeling. Biopolymers. 54:11-26.
108. Platt FM, Neises GR, Dwek RA, Butters TD. 1994. N Butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J Biol Chem. 269:8362-8365.
109. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-D-N-acetylneuraminate) substrate. Anal Biochem. 94:287 296.
110. Prestegard JH. 1998. New techniques in structural NMR - anisotropic interactions. Nat Struct Biol. 5:517.
111. Prestegard JH, Bougault CM, Kishore AI. 2004. Residual dipolar couplings in structure determination of biomolecules. Chem Rev. 104:3519-3540.
112. Rarey M, Kramer B, Lengauer T. 1999. The particle concept: Placing discrete water molecules during protein-ligand docking predictions. Proteins. 34:17-28.
113. Rostand KS and Esko JD. 1997. Microbial adherence to and invasion through proteoglycans. Infect Immun. 65:1-8.
114. 13-14F3 fragment of fibronectin. J Biol Chem. 277:50629-50635.
115. Sahoo SS, Thomas C, Sheth A, Henson C, York WS. 2005. GLYDE - an expressive XML standard for the representation of glycan structure. Carbohydr Res. 340:2802.
116. Sandstrom C, Berteau O, Gemma E, Oscarson S, Kenne L, Gronenborn AM. 2004. Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR. Biochemistry. 43:13926-13931.
117. Sayers EW and Prestegard JH. 2000. Solution conformations of a trimannoside from nuclear magnetic resonance and molecular dynamics simulations. Biophys J. 79:3313-3329.
118. Sayers EW and Prestegard JH. 2002. Conformation of a trimannoside bound to mannose-binding protein by nuclear magnetic resonance and molecular dynamics simulations. Biophys J. 82:2683-2699.
119. Schmitz A and Galas DJ. 1980. Sequence-specific interactions of the tight-binding I12-X86 lac repressor with non-operator DNA. Nucleic Acids Res. 8:487-506.
120. Schwieters CD, Kuszewski JJ, Clore GM. 2006. Using Xplor-NIH for NMR molecular structure determination. Prog Nucl Magn Reson Spectrosc. 48:47-62.
121. Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM. 2003. The Xplor-NIH NMR molecular structure determination package. J Magn Reson. 160:65-73.
122. Scott WRP, Hunenberger PH, Tironi IG, Mark AE, Billeter SR, Fennen J, Torda AE, Huber T, Kruger P, et al. 1999. The GROMOS biomolecular simulation program package. J Phys Chem. 103:3596-3607.
123. Seyfried NT, Atwood JA,, Almond A, Day AJ, Orlando R, Woods RJ. 2007. Fourier transform mass spectrometry to monitor hyaluronan - protein interactions: Use of hydrogen/deuterium amide exchange. Rapid Commun Mass Spectrom. 21:121-131.
124. Sharon N and Lis H. 1993. Carbohydrates in cell recognition. Sci Am 268:82-89.
125. Sharp JS, Becker JM, Hettich RL. 2003. Protein surface mapping by chemical oxidation: Structural analysis by mass spectrometry. Analyt Biochem. 313:216-225.
126. Sharp JS, Becker JM, Hettich RL. 2004. Analysis of protein solvent accessible surfaces by photochemical oxidation and mass spectrometry. Anal Biochem. 76:672-683.
127. Sheshberadaran H and Payne LG. 1988. Protein antigen monoclonal-antibody contact sites investigated by limited proteolysis of monoclonal antibody-bound antigen - protein footprinting. Proc Natl Acad Sci USA 85:1-5.
128. Sly WS and Vogler C. 2002. Brain-directed gene therapy for lysosomal storage disease: Going well beyond the blood-brain barrier. Proc Natl Acad Sci USA. 99:5760-5762.
129. Smith DC, Lord JM, Roberts LA, Johannes L. 2004. Glycosphingolipids as toxin receptors. Semin Cell Dev Biol. 15:397-408.
130. Sugita Y and Okamoto Y. 1999. Replica-exchange molecular dynamics method for protein folding. Chem Phys Lett. 314:141.
131. Swanson JMJ, Henchman RH, McCammon JA. 2004. Revisiting free energy calculations: A theoretical connection to MM/PBSA and direct calculation of the association free energy. Biophys J. 86:67-74.
132. Takamoto K and Chance MR. 2006. Radiolytic protein footprinting with mass spectrometry to probe the structure of macromolecular complexes. Annu Rev Biophys Biomol Struct. 35:251-276.
133. Tessier MB, DeMarco ML, Yongye A, Woods RJ. 2007. Extension of the GLY-CAM06 biomolecular force field to lipids, lipid bilayers and glycolipids. Mol Sim. In press.
134. Todeschini AR, Girard MF, Wieruszeski J-M, Nunes MP, DosReis GA, Mendonca-Previato L, Previato JO. 2002. Trans-sialidase from Trypanosoma cruzi binds host T-lymphocytes in a lectin manner. J Biol Chem. 277:45962-45968.
135. Valafar H and Prestegard JH. 2004. REDCAT: A residual dipolar coupling analysis tool. J Magn Reson. 167:228-241.
136. Vallee F, Karaveg K, Herscovics A, Moremen KW, Howell PL. 2000. Structural basis for catalysis and inhibition of N-glycan processing class I alpha 1,2-mannosidases. J Biol Chem. 275:41287-41298.
137. Varki A. 1993. Biological roles of oligosaccharides: All of the theories are correct. Glycobiology. 3:97-130.
138. Vliegenhart JFG and Woods RJ. 2006. NMR spectroscopy and computer modeling of carbohydrates. Recent advances. ACS Symp. Ser.
139. von Itzstein M, Wu W-Y, Kok GB, Pegg MS, Dyason JC, Jin B, Phan TV, Smythe ML, White HF, et al. 1993. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 363:418.
140. Wang XD and Padgett RA. 1989. Hydroxyl radical footprinting of RNA - Application to pre-messenger RNA splicing complexes. Proc Natl Acad Sci USA. 86:7795-7799.
141. Watson KA, Chrysina ED, Tsitsanou KE, Zographos SE, Archontis G, Fleet GWJ, Oikonomakos NG. 2005. Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase. Proteins, 61:966-983.
142. Webb LMC, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA. 90:7158-7162.
143. Wen X, Yuan Y, Kuntz DA, Rose DR, Pinto BM. 2005. A combined STD-NMR/ molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi a-mannosidase II. Biochemistry. 44:6729-6737.
144. Woods RJ, Dwek RA, Edge CJ, Fraserreid B. 1995. Molecular mechanical and molecular dynamical simulations of glycoproteins and oligosaccharides: 1. GLYCAM-93 parameter development. J Phys Chem. 99:3832-3846.
145. Xu G and Chance MR. 2005. Radiolytic modification and reactivity of amino acid residues serving as structural probes for protein footprinting. Anal Chem.77:4549-4555.
146. Xu G, Talkamoto K, Chance MR. 2003. Radiolytic modification of basic amino acid residues in peptides: Probes for examining protein-protein interactions. Anal Chem. 75:6995-7007.
147. Xu Y, Sette A, Sidney J, Gendler SJ, Franco A. 2005. Tumor-associated carbohydrate antigens: A possible avenue for cancer prevention. Immunol Cell Biol. 83:440-448.
148. Yan J, Kline AD, Mo H, Shapiro MJ, Zartler ER. 2003. The effect of relaxation on the epitope mapping by saturation transfer difference NMR. J Magn Reson. 163:270.
149. Yates JR, Eng JK, Mccormack AL, Schieltz D. 1995. Method to correlate tandem mass-spectra of modified peptides to amino-acid-sequences in the protein database. Anal Chem. 67:1426-1436.
150. 13C-labeled acetyl groups. J Am Chem Soc. 129:13288-13297.
151. Zwanzig RW. 1954. High-temperature equation of state by a perturbation method: 1. Nonpolar gases. J Chem Phys. 22:1420-1426.